Toulouse, France

Akli Ben Imeddourene

This inventor holds 2 USPTO granted patents. Top assignees: Institut National Des Sciences Appliquees De Toulouse, Institut Pasteur, Centre National De La Recherche Scientifique. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akli Ben Imeddourene. Retrieved from https://idiyas.com/inventor/akli-ben-imeddourene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Oligosaccharide Synthesis by Akli Ben Imeddourene

Introduction

Akli Ben Imeddourene is a notable inventor based in Toulouse, France. He has contributed significantly to the field of oligosaccharide synthesis, focusing on the preparation and application of protected tetrasaccharides. His innovative work is both vital to the scientific community and has practical implications in various biotechnological applications.

Latest Patents

Among his achievements, Akli Ben Imeddourene holds a patent titled "Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of specific oligosaccharides." This patent details a process for preparing protected tetrasaccharides and their utilization in synthesizing oligosaccharides, particularly in producing fragments of O-antigens associated with various serotypes.

Career Highlights

Throughout his career, Akli has collaborated with esteemed institutions such as the Institut Pasteur and the Institut National de la Recherche Agronomique. His work at these organizations has allowed him to push the boundaries of research in the field of glycoscience, especially concerning the functional applications of oligosaccharides.

Collaborations

Akli's innovative efforts have been enriched through collaboration with skilled colleagues, including Laurence Mulard and Guillaume Le Heiget. Their contributions have helped advance the research landscape in which Akli operates, fostering a collaborative environment that emphasizes innovation and excellence.

Conclusion

In summary, Akli Ben Imeddourene's contributions to oligosaccharide synthesis through his patent represent an important advancement in the field. His work not only furthers scientific understanding but also opens up possibilities for future applications in health and biotechnology. His collaborations with prominent institutions and colleagues further signify the value of teamwork in driving innovation forward.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…